期刊文献+

胰腺印戒细胞癌四例临床分析 被引量:1

Signet ring cell carcinoma of pancreas: a report of 4 cases
原文传递
导出
摘要 目的 探讨胰腺印戎细胞癌的诊治.方法 回顾性分析天津肿瘤医院收治的、经手术病理证实的胰腺印戒细胞癌患者临床资料.结果 共4例胰腺印戒细胞癌病例,临床表现无特异性,主要症状有:上腹胀痛,可伴背痛和皮肤、巩膜黄染.1例患者癌抗原19-9和癌胚抗原增高.4例患者均行姑息性短路手术,术中行活检.平均生存期为2.8个月.结论 胰腺印戒细胞癌发病率低,预后差.手术是目前有效的治疗手段,但切除率低.化疗效果有待进一步证实. Objective To analyze the investigation and treatment of signet ring cell carcinoma of pancreas.Method The clinical data of patients with histopathologically confirmed signet ring cell carcinoma of pancreas were analyzed retrospectively.Results There were 4 patients with signet ring cell carcinoma.There was no patient who presented with a typical carcinoid syndrome.Most patients presented with upper abdominal pain,backache or jaundice caused by bile duct obstruction.In one patient CA19-9 and CEA were raised.All patients received palliative biliary bypass and needle biopsy of the tumour.The median survival was 2.8 months.Conclusions Pancreatic signet ring cell carcinoma is a rare disease with poor prognosis.Surgery is the only effective treatment but the resectability rate is low.Whether this tumour responds to chemotherapy requires further studies.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第1期50-51,共2页 Chinese Journal of Hepatobiliary Surgery
关键词 胰腺肿瘤 印戒细胞 Pancreatic neoplasm Carcinoma, signet ring cell
  • 相关文献

参考文献2

二级参考文献17

  • 1上海市疾病预防控制中心.2009年上海市恶性肿瘤报告.www.scdc.sh.cn.
  • 2Klinkenbijl JH, Jeekel J, Sahmoud T. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pan- creas and periampullary region: phase Ⅲ trial of the EORTC gastrointestinal tract cancer cooperative group[J]. Ann Surg, 1999,230:776-782.
  • 3Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J]. N Engl J Med, 2004,350 : 1200-1210.
  • 4Pieozzi VJ, Kozarek RA, Traverso LW, et al. Interferon- based adjuvant chemoradiation therapy after pancreatieoduode- nectomy for panereatic adenocarcinoma[J]. Am J Surg, 2003, 185:476-480.
  • 5Desai S, Ben-Josef E, Griffith KA, et al. Gemcitabine-based combination chemotherapy followed by radiation with capecit- abine as adjuvant therapy for resected pancreas cancer[J]. Int J Radiat Oncol Biol Phys, 2009,75:1450-1455.
  • 6Stessin AM, Meyer JE, Sherr DL. Patients with respectable pancreatic cancer: an analysis of data from the surveillance, epidemiology and end results (SEER) registry[J]. Int J Radiat Oncol Biol Plays, 2008,72:1128~1133.
  • 7Moody JS, Sawrie SM, Kozak KR, et aI. Adjuvant radiother- apy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients[J]. J Gastroenterol, 2009,44 84-91.
  • 8Artinyan A, Anaya DA, Mckenzie S, et al. Neoadjuvant ther- apy is associated with improved survival in resectalbe pancreat- ic adenocarcinoma[J]. Cancer, 2011,117: 2044-2049.
  • 9Abbott DE, Baker MS, Talamonti MS. Neoadjuvant therapy for pancreatic cancer: a current review[M]. J Surg Oncol, 2010,101:315 320.
  • 10Regine WF, Winter KA, Abrams RA, et al. Fluorouraeil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcino- rna: a randomized controlled trial[J]. JAMA, 2008, 299: 1019-1026.

共引文献7

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部